Beating Merkel Cell Carcinoma With Immunotherapy

Carrie Best was told she had just weeks to live before she found a clinical trial of an immunotherapeutic for her rare and aggressive form of skin cancer. Thanks to that trial, avelumab became the first treatment for Merkel cell carcinoma approved by the FDA. Read Carrie’s story and those of other survivors in the AACR Cancer Progress Report 2017 here: http://cancerprogressreport.or....g/Pages/cpr17-surviv

• Kategorya